Treatment outcomes of multidrug resistant tuberculosis (MDR TB) treated with bedaquiline under programmatic management of drug resistant tuberculosis at a tertiary care hospital in Punjab, India-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment outcomes of multidrug resistant tuberculosis (MDR TB) treated with bedaquiline under programmatic management of drug resistant tuberculosis at a tertiary care hospital in Punjab, India

Published:2023-12 Issue: Volume: Page:
ISSN:0019-5707
Container-title:Indian Journal of Tuberculosis
language:en
Short-container-title:Indian Journal of Tuberculosis

Author:

Kumari Dr Sudesh,Gupta Dr Aditi,Chopra Dr Vishal,Kaur Dr Snehinder

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference26 articles.

1. TB : A Global Emergency, WHO Report on the TB Epidemic;Who Global Tuberculosis Programme,1994

2. Global Tuberculosis Report 2021,2021

3. Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions;Janmeja;Indian J Tubercul,2018

4. Evolution of newer regimens in TB from RNTCP to NTEP;Gupta;Indian J Tubercul,2020

5. Bedaquiline and delamanid in tuberculosis;Esposito;Expert Opin Pharmacother,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP